(MENAFN- EIN Presswire)
Emergen Research Logo
The Global Molecular Diagnostics Point of Care Market is projected to reach USD 4.84 billion in 2027. The main factors that are expected to strengthen high
VANCOUVER, BC, CANADA, September 22, 2022 /EINPresswire.com / -- The Global Molecular Diagnostics Point of Care Market is projected to reach USD 4.84 billion in 2027. The main factors that are expected to strengthen high growth potential for POC MDx products are continuing research and development to miniaturize tests with molecular diagnostics that enable increased patient testing with higher precision and lower turnaround times.
Increasing demand in non-laboratory environments like pharmacy clinics, doctors, and home care tests, which are, by definition, portable and safe, would likely lead to lower demand on the market over the forecast period. The demand is expected to increase in CLIA tests. A number of large international bodies, including governments of developing countries, actively support and finance continuous research and development.
In addition, a wide variety of point-of-care testing technologies has been evolving rapidly over the previous decade with a view to extending its potential market to a wider range of Medical Faculties, initially focused on the screening, monitoring, and diagnosis of infectious diseases in low income developing countries. Therefore, cardiological monitoring, oncological testing, and hematological testing are now available and/or under development.
Recent developments in microfluidics and genetic sequencing equipment have paved the way for the creation of cost-effective, highly precise, and fast test platforms that can be used as POC systems. This is a major factor that contributes substantially to the well-funded, high growth potential of the PoC molecular diagnostics market.
To know about more drivers and challenges | Download a PDF sample now: @
Molecular Diagnostics Point of Care Market Report 2020 is one of a series of new reports from The Emergen Research Company that provides plant factory industry overview, Molecular Diagnostics Point of Care market analysis and forecasts market size and growth for the global plant factory market, Molecular Diagnostics Point of Care market segments and geographies, Molecular Diagnostics Point of Care market players, Molecular Diagnostics Point of Care market leading competitor revenues, profiles and market shares. The plant factory market research report identifies top countries and segments for opportunities and strategies based on market trends and key competitors' approaches.
Molecular Diagnostics Point of Care Market: Analysis by focusing on Competitive landscape and Key Developments
Abbott Laboratories, Bayer Healthcare, Roche Diagnostics, Bio-Rad Laboratories, Danaher Corporation, BioMerieux, Dako, Abaxis Inc., OraSure Technologies Inc., and Nipro Diagnostics, among others.
Access the full study findings here:
The research then uncovers market opportunities that are simple and gives the business valuable information that will help it thrive in the global Molecular Diagnostics Point of Care market. The report contains detailed information on the factors that will increase the market's growth over the next few years, from 2020-2027. The report discusses market segmentation, key players and types of applications, as well as rapid growth in key markets.
key findings from the report suggest
POC MDx research is used in the majority of consumer incomes for infectious diseases due to the existence of several big business companies with a wide product selection.
Another factor accountable for the dominance of this section is the rising burden of infectious disease in developed and developing countries.
The biggest business segment to produce sales is PCR-based POC studies. The widespread use of PCR-based technology for PCR products for molecular diagnosis and marketing has created plenty of incentives for the growth of the segment.
North America was the largest region, contributing much of the world's revenue due to the existence of the highly technical, medical system, government, and private investments in R&D to improve MDx POC tests.
In May 2020, Becton Dickinson to extend the MDx diagnostic acquisition to the points of care
For the purpose of this report, Emergen Research has segmented into the global Molecular Diagnostics Point of Care Market on the basis of Test Location, Technology, Application, End-Use, and region:
Test Location Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
Technology Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
Application Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
End-Use Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
Assisted Living Healthcare Facilities
The study segments the Molecular Diagnostics Point of Care industry in light of major classification such as product type, potential markets, application, and end-user. This industry assessment for the forecast period, 2020 – 2027 incorporates projections pertaining to the investment feasibility, gross margin, profits, consumption volume, production capability and major market vendors. Likewise, statistics associated with the competitive landscape, shifting consumer behaviour and spending power is showcased and well-explained with the help of treasured resources such as charts, graphs and graphic images, which can be easily incorporated in the business or corporate presentations.
Get an Impressive Discount on this Report@
How will the Molecular Diagnostics Point of Care Market, 2020 to 2027 report help you?
In summary, our 250-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for Molecular Diagnostics Point of Care Market, 2020 to 2027 Market, with forecasts for include report segmentation and company size, each forecast at a global and regional level – discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2027 for four regional and 20 key national markets – See forecasts for the Molecular Diagnostics Point of Care Market, 2020 to 2027 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Molecular Diagnostics Point of Care Market, 2020 to 2027.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Key point summary of the report:
The report offers a comprehensive overview of the market size, share, and growth rate in the forecast duration.
It provides details about current scenario, historical data, giving an accurate market forecast for the coming years.
The study categorizes the market on the basis of product types, applications, end users, market value and volume, business verticals, and 5 major regions.
It also offers regional market analysis and forecast for prominent geographies in the sector viz., North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Industry supply chain, sourcing strategy, upstream feedstock, and downstream demand analysis has also been undertaken in the research report.
The study offers a comprehensive understanding of the demand and supply dynamics, including production and consumption rates, and mapping of the overall market.
The report employs different analytical tools including, SWOT analysis, Porter's five forces analysis, and pricing analysis, to give precise market information.
Request a customization of the report @
Looking for something else? Here is a list of similar reports by Emergen Research
4D Printing Market
Assessment Services Market
Thank you for reading the research report. We also offer report customization as per client requirement. Kindly connect with us to know more about the customization feature and our team will offer you the best suited report.
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade
+91 90210 91709
email us here
Visit us on social media: